Belgian pharmaceutical company UCB SA has sued drug-maker Teva Pharmaceutical Industries to stop it manufacturing a generic version of epilepsy drug Vimpat.
If you have already subscribed please login.
If you have any technical issues please email tech support.
ucb, teva, anda, vimpat, lacosamide
